MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY

Clinical trials for MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY trials appear

Sign up with your email to follow new studies for MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for myeloma patients with failing kidneys: drug combo shows promise

Disease control Recruiting now

This study tests a combination of two drugs (CM336 and isatuximab) in 20 people newly diagnosed with multiple myeloma who also have severe kidney impairment. The goal is to see if the treatment can improve kidney function and control the cancer. Participants receive three cycles …

Matched conditions: MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 17, 2026 02:06 UTC

MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY

Get alerted when new MULTIPLE MYELOMA LIGHT CHAIN INDUCED RENAL INSUFFICIENCY trials appear

New hope for myeloma patients with failing kidneys: drug combo shows promise